Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2024 Oct 1;33(4):160-166.
doi: 10.1097/MCD.0000000000000490. Epub 2024 Jul 16.

Report of a novel recurrent homozygous variant c.620A>T in three unrelated families with thiamine metabolism dysfunction syndrome 5 and review of literature

Affiliations
Review

Report of a novel recurrent homozygous variant c.620A>T in three unrelated families with thiamine metabolism dysfunction syndrome 5 and review of literature

Selinda Mascarenhas et al. Clin Dysmorphol. .

Abstract

Introduction: Biallelic variants in thiamine pyrophosphokinase 1 ( TPK1 ) are known to cause thiamine metabolism dysfunction syndrome 5 (THMD5). This disorder is characterized by neuroregression, ataxia and dystonia with basal ganglia abnormalities on neuroimaging. To date, 27 families have been reported with THMD5 due to variants in TPK1 .

Methods: We ascertained three individuals from three unrelated families. Singleton exome sequencing was performed on all three individuals, followed by in silico mutagenesis of the mutant TPK protein. Additionally, we reviewed the genotypic and phenotypic information of 27 previously reported individuals with THMD5.

Results: Singleton exome sequencing revealed a novel homozygous variant c.620A>T p.(Asp207Val) in TPK1 (NM_022445.4) in all three individuals. In silico mutagenesis of the mutant protein revealed a decrease in protein stability and altered interactions with its neighboring residues compared to the wild-type protein. Thus, based on strikingly similar clinical and radiological findings compared to the previously reported individuals and with the support of in silico mutagenesis findings, the above-mentioned variant appears to be the probable cause for the condition observed in the affected individuals in this study.

Conclusion: We report a novel homozygous variant in TPK1 , which appears to be recurrent among the Indian population.

PubMed Disclaimer

Conflict of interest statement

Conflict of interest

The authors declare no conflict of interest.

Figures

Figure 1.
Figure 1.
(A-C) Pedigrees for family 1, 2 and 3, respectively (D) Magnetic resonance imaging (MRI) showing (Di - vi) T2-weighted/FLAIR hyperintensities in caudate and putamen in proband 1, 2 and 3 (P1, P2 and P3), respectively. In addition, (Diii-iv) P2 had hyperintensities in the periventricular white matter and (Dv-vi) P3 showed mild cerebral volume loss and cortical atrophy. (E) Multiple sequence alignment (MSA) of TPK sequences showing the 207th position is not conserved across species. The asterisk (*) denotes a fully conserved residue, colon (:) denotes residues with strongly similar properties and period (.) denotes residues with weakly similar properties. (F) Structure of human TPK showing two chains, A (red) and B (dark blue) with thiamine pyrophosphate (TPP) (green) bound to it. (Fi) In the wild-type protein, Asp207 (yellow) has polar contacts (orange lines) with Val195 (pink) and Thr205 (light blue). (Fii) In silico mutagenesis revealed loss of polar contact with Thr205 in the mutant TPK protein. (G) Schematic representation of TPK1 gene with all reported variants along with the variant reported in our study represented in red.

References

    1. Au LWC, Lee HHC, Sheng B, Chan KY, Yau EKC, Mak CM, et al. (2020). Movement disorders associated with thiamine pyrophosphokinase deficiency: Intrafamilial variability in the phenotype. Clin Neurol Neurosurg, 199:106258. - PubMed
    1. Banka S, de Goede C, Yue WW, Morris AA, von Bremen B, Chandler KE, et al. (2014). Expanding the clinical and molecular spectrum of thiamine pyrophosphokinase deficiency: a treatable neurological disorder caused by TPK1 mutations. Mol Genet Metab, 113:301–306. - PubMed
    1. Bugiardini E, Pope S, Feichtinger RG, Poole OV, Pittman AM, Woodward CE, et al. (2019). Utility of whole blood thiamine pyrophosphate evaluation in TPK1-related diseases.. J Clin Med, 8. - PMC - PubMed
    1. Eckenweiler M, Mayr JA, Grünert S, Abicht A, Korinthenberg R (2021). Thiamine Treatment and Favorable Outcome in an Infant with Biallelic TPK1 Variants. Neuropediatrics, 52:123–125. - PubMed
    1. Ferreira-Vieira TH, de Freitas-Silva DM, Ribeiro AF, Pereira SR, Ribeiro  (2016). Perinatal thiamine restriction affects central GABA and glutamate concentrations and motor behavior of adult rat offspring. Neurosci Lett, 617:182–187. - PubMed